Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Freeport-McMoRan Inc (FCX) vs Stryker Corporation (SYK) Price & Performance

Freeport-McMoRan IncTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Freeport-McMoRan Inc vs Stryker Corporation — how do they compare? Freeport-McMoRan Inc trades at $59.39 (market cap $87.65B), while Stryker Corporation trades at $330.44 (market cap $121.31B). The key difference: Stryker Corporation is the larger of the two by market cap, and Stryker Corporation pays the higher dividend (1.11%). Which is the better fit depends on your goals.

FCXSYK
Market Cap
$87.65B$121.31B
Sector
Basic MaterialsTechnology
52-Week High
$71.73$403.53
52-Week Low
$35.34$282.58
Enterprise Value
$94.31B$133.07B
Dividend Yield
0.98%1.11%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Freeport-McMoRan Inc

Freeport-McMoRan (FCX) trades at $61.97, up 3.33% with a bearish technical signal despite three consecutive quarterly earnings beats. The copper miner shows improving fundamentals with revenue growth to $25.92B and net income of $2.20B in 2025, supported by strong copper demand. Analyst consensus remains bullish with a $72.94 price target, though the stock faces technical resistance near $63-64 levels.

FCX presents a compelling value proposition with expanding profit margins and strategic positioning in the copper market, though investors face volatility risks from commodity price fluctuations and ongoing negative cash flow trends. The company's expansion pipeline and dividend payments provide additional shareholder value drivers.

Stryker Corporation

Stryker (SYK) trades at $330.48, up 6.19% with strong analyst support (74% buy ratings) and a $388.44 consensus price target. The stock shows bearish technical signals despite recent earnings beats in Q3 and Q4 2025, offset by a Q1 2026 miss attributed to a temporary cyber disruption. Fundamentals remain solid with 63.83% gross margins and 13.21% net income margin, while the company continues innovation with Mako robotics expansion and new product launches.

The outlook remains positive given maintained full-year guidance and healthy end-market demand. Key risks include cybersecurity vulnerabilities and competitive pressures, but institutional confidence is high with no sell ratings. The current valuation at 36.63 P/E offers potential upside to the price target, supported by robust cash flow generation and dividend consistency.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Freeport-McMoRan Inc

Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia

Read more on FCX

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK